Else Nutrition Holdings Inc. (BABYF) Stock Analysis
Educational signal · not a buy or sell recommendation · How to read this
Beta 0.98: the stock has moved roughly in step with the S&P 500.
For informational purposes only. Not financial advice. Machine-generated analysis by Stock Expert AI — model gemini-2.0-flash, generated Mar 16, 2026. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR
Quick AnswerElse Nutrition Holdings Inc. (BABYF) trades at $0.18. Else Nutrition Holdings Inc. focuses on developing and selling plant-based food and nutrition products for infants, toddlers, children, and adults in North America and Israel. Sector: Consumer defensive.
Price as of Sep 11, 2026 · Last analyzed: Mar 16, 2026Analyst Coverage for BABYF: BABYF does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates BABYF against Consumer Defensive peers across nine fundamental dimensions and assigns a neutral fundamental signal based on the underlying data.
No score published: this stock trades under $10,000 on a typical day, so the price beside it is not one you could reliably act on.
BABYF: 1/2 scored disciplines lean bearish. Dominant signal: Ray Dalio bullish.
How is this calculated? →AI simulations built from the named investors' published principles. Not affiliated with, endorsed by, or the opinion of these individuals. How these lenses are built
Else Nutrition Holdings Inc. (BABYF) Consumer Business Overview
Else Nutrition Holdings Inc. develops, produces, and sells plant-based nutritional products targeting infants, toddlers, children, and adults, primarily in North America and Israel. With a focus on online sales, the company competes in the packaged foods sector, offering alternatives to traditional dairy-based products, though facing challenges with profitability and market penetration.
What Is the Investment Thesis for BABYF?
Key value drivers include expanding its product line and increasing online sales. The company's focus on plant-based nutrition aligns with growing health and environmental consciousness among consumers. However, the company's negative profit margin of -149.2% and gross margin of -32.4% raise concerns about its financial sustainability. A beta of 0.98 suggests market correlation. Growth catalysts include potential partnerships with major retailers and expansion into new geographic markets. Investors should closely monitor the company's ability to improve its financial performance and achieve profitability. The absence of dividends further impacts investor returns.
Based on FMP financials and quantitative analysis
BABYF Key Highlights
Market capitalization of $0.00B indicates a micro-cap company with high growth potential but also significant risk.
- Negative P/E ratio of -0.28 reflects current unprofitability, requiring investors to focus on future earnings potential.
- Profit Margin of -149.2% highlights significant operational challenges and the need for improved cost management.
- Gross Margin of -32.4% indicates that the cost of goods sold exceeds revenue, necessitating a strategic overhaul of pricing or production efficiency.
- Beta of 0.98 suggests the stock's volatility is similar to the overall market.
Who Are BABYF's Competitors?
BABYF is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | MoonshotScore |
|---|---|---|---|---|
| NSRGF Nestlé S.A. | $95.39 | +0.94% | $245B | 419-signal |
| GPDNF Danone S.A. | $71.54 | -3.76% | $45.9B | 449-signal |
| JBS JBS N.V. | $12.62 | +0.32% | $28.0B | 945-pillar |
| GIS General Mills, Inc. | $35.96 | -3.05% | $19.2B | 545-pillar |
| MKC-V McCormick & Company | $58.10 | +4.59% | $15.6B | 469-signal |
| KRYAF Kerry Group plc | $97.25 | 0.00% | $15.5B | 469-signal |
| BMBOY Grupo Bimbo, S.A.B. de C.V. | $13.44 | -3.70% | $14.5B | 479-signal |
| SJM The J. M. Smucker Company | $122.01 | -1.05% | $13.0B | 645-pillar |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance This table mixes two scoring engines — compare a number only with others carrying the same tag.
What Are BABYF's Key Strengths?
Focus on plant-based nutrition.
- Innovative product development.
- Online sales channel.
- Growing brand awareness.
What Are BABYF's Weaknesses?
Negative profit margin.
- Limited market share.
- Dependence on online sales.
- Small company size.
What Could Drive BABYF Stock Higher?
Potential partnerships with major retailers to expand distribution network.
- Launch of new plant-based nutrition products targeting specific dietary needs.
- Increasing consumer demand for plant-based alternatives to traditional dairy products.
- Expansion of online sales channel to reach a wider audience.
- Growing awareness of the health and environmental benefits of plant-based nutrition.
What Are the Key Risks for BABYF?
Financial-distress signal — its Altman Z-Score of -44.02 sits in the distress zone (elevated bankruptcy risk).
- Weak fundamentals — a Piotroski F-Score of 2/9 flags soft profitability, leverage or efficiency.
- Intense competition from established players in the food and beverage industry.
- Changing consumer preferences and trends in the plant-based food market.
- Regulatory changes impacting the production and marketing of plant-based products.
- Negative profit margin and financial sustainability concerns.
- Limited market share and brand recognition compared to larger competitors.
What Are the Growth Opportunities for BABYF?
- Expansion of Product Line: Else Nutrition can capitalize on the growing demand for plant-based products by expanding its product line to include new flavors and formulations. Timeline: Within the next 1-2 years, Else Nutrition can introduce new products targeting specific dietary needs and preferences.
- Increased Online Sales: Else Nutrition can leverage its online platform to reach a wider audience and increase sales. The e-commerce channel is experiencing rapid growth, with online food sales projected to reach $340 billion by 2027. By optimizing its online presence and investing in digital marketing, Else Nutrition can drive sales growth and improve its brand awareness. Timeline: Ongoing, with continuous improvements to the online platform and marketing strategies.
- Partnerships with Major Retailers: Else Nutrition can expand its distribution network by partnering with major retailers to make its products more accessible to consumers. Retail partnerships can significantly increase brand visibility and drive sales volume. The retail channel accounts for a significant portion of food sales, making it a crucial area for growth. Timeline: Within the next 2-3 years, Else Nutrition can establish partnerships with key retailers in North America and Israel.
- Geographic Expansion: Else Nutrition can expand its operations into new geographic markets to tap into the growing demand for plant-based nutrition products globally. The Asia-Pacific region is experiencing rapid growth in the plant-based food market, presenting a significant opportunity for Else Nutrition. Timeline: Within the next 3-5 years, Else Nutrition can explore opportunities to enter new markets in Asia and Europe.
- Focus on Sustainability: Else Nutrition can strengthen its brand image and attract environmentally conscious consumers by emphasizing its commitment to sustainability. Consumers are increasingly seeking products that are environmentally friendly and ethically sourced. By highlighting its sustainable practices, Else Nutrition can differentiate itself from competitors and build brand loyalty. Timeline: Ongoing, with continuous efforts to improve sustainability across its operations.
What Are BABYF's Competitive Advantages?
- Focus on plant-based nutrition for infants and children.
- Proprietary formulations and manufacturing processes.
- Strong brand reputation for quality and innovation.
- Established online sales channel.
What Does BABYF Do?
Else Nutrition Holdings Inc., headquartered in Tel Aviv-Yafo, Israel, is a food and nutrition company focused on developing plant-based alternatives to traditional dairy-based products for infants, toddlers, children, and adults. The company was founded with the mission of providing clean-label, whole-food nutrition solutions. Else Nutrition offers a range of products, including plant-based baby formula, toddler nutrition, and complementary food products. Their product line includes baby snacks, feeding accessories like bottles and teats, and nutrition products tailored for different age groups. The company distributes its products primarily through online channels, targeting health-conscious consumers seeking plant-based options. Else Nutrition aims to differentiate itself through its focus on whole-food ingredients and its commitment to providing nutritionally complete alternatives to conventional dairy-based products. The company operates in North America and Israel, seeking to expand its market presence in the growing plant-based food sector. Despite its innovative product offerings, Else Nutrition faces challenges related to profitability, as indicated by its negative profit and gross margins.
What Products and Services Does BABYF Offer?
- Develops plant-based food and nutrition products.
- Produces baby snacks and feeding accessories.
- Offers plant-based baby formula products.
- Creates toddler, children, and adult nutrition products.
- Provides complementary food products.
- Sells products online in North America and Israel.
How Does BABYF Make Money?
- Develops and manufactures plant-based nutrition products.
- Sells products directly to consumers through online channels.
- Partners with retailers for distribution.
- Focuses on marketing and branding to build brand awareness.
What Industry Does BABYF Operate In?
Else Nutrition operates within the rapidly expanding plant-based food and beverage industry. The global plant-based food market is experiencing substantial growth, driven by increasing consumer awareness of health, environmental, and ethical concerns related to animal products. Competitors include companies like AMNC, CMGHF, CULTF, CYAN, and HRSR, which also offer alternative nutrition products. Else Nutrition differentiates itself through its focus on plant-based nutrition for infants and children. The industry is characterized by innovation in product development and increasing competition for market share. Else Nutrition's success depends on its ability to effectively market its products and establish a strong brand presence.
Who Are BABYF's Key Customers?
- Infants and toddlers requiring nutritional support.
- Parents seeking plant-based alternatives to traditional dairy products.
- Children and adults looking for healthy nutrition options.
- Health-conscious consumers in North America and Israel.
Research confidence
Thin evidence — scoring coverage unknown. Treat this as a starting point, not a conclusion.
- ● Scoring coverage unknown
- ● Price is current
- ● Latest filing 164 days ago
- ● No analyst coverage
- ● Reported in CAD, converted to USD
MoonshotScore History
Recorded daily since 2026-08-23 · 19 snapshots
| 2026-08-23 | 44 |
| 2026-08-26 | 44 |
| 2026-08-29 | 44 |
| 2026-09-01 | 44 |
| 2026-09-04 | 44 |
| 2026-09-07 | 44 |
| 2026-09-10 | 44 |
What changed?
The score has stayed at 44.
Over the same 18 days the stock moved +109.3%.
Company Profile
Else Nutrition Holdings Inc. operates in the Packaged Foods industry within the Consumer Defensive sector. It is headquartered in Tel Aviv, IL. The company is led by CEO Hamutal Yitzhak. BABYF has traded publicly since 2019.
Financial Health
Else Nutrition Holdings Inc.'s Piotroski F-Score is 2/9, a 9-point checklist of profitability, leverage and efficiency — flagging fundamental weakness worth scrutiny. Its Altman Z-Score of -44.02 places it in the distress zone, a signal of elevated financial risk.
Key Financial Metrics
Return on equity for Else Nutrition Holdings Inc. stands at 228.3%, a gauge of how efficiently it converts shareholder capital into profit. A current ratio of 0.39 means current liabilities exceed short-term assets, a liquidity point worth watching.
Quarterly Financial Performance: Else Nutrition Holdings Inc.
Revenue for Else Nutrition Holdings Inc. came in at $1.1M during Q1 FY2026, a 90.3% improvement versus the preceding quarter. The company recorded a net loss of $403K, with diluted EPS of $-0.09. Quarter-over-quarter revenue has been mixed, typical for a unknown company operating in Consumer Defensive. Across the four most recent quarters, BABYF averaged $-0.29 in diluted EPS.
Earnings Track Record
Else Nutrition Holdings Inc. has beaten Wall Street's EPS estimate in 4 of its last 8 reported quarters — more hits than misses. Reported results have landed about 48.3% below estimates on average.
BABYF Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis · FY 2025
Bull Case vs Bear Case
Bull Case
- Focus on plant-based nutrition.
- Innovative product development.
- Online sales channel.
- Growing brand awareness.
Bear Case
- Negative profit margin.
- Limited market share.
- Dependence on online sales.
- Small company size.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · March 2026
Recent Quarterly Results
| Quarter | Revenue | Net Income | EPS |
|---|---|---|---|
| Q1 FY2026 | $1M | -$403,401.716 | -$0.09 |
| Q4 FY2025 | $559,101.636 | -$2M | -$0.58 |
| Q3 FY2025 | $1M | -$434,090.16 | -$0.14 |
| Q2 FY2025 | $1M | -$1M | -$0.34 |
Q1 FY2026 · filed 31 Mar 2026 · SEC EDGAR →
Based on FMP financials and quantitative analysis · Converted to USD from CAD at today's rate
BABYF Latest News
-
Stocks That Hit 52-Week Highs On Tuesday
· Mar 24, 2020
-
Stocks That Hit 52-Week Highs On Wednesday
· Feb 26, 2020
-
Stocks That Hit 52-Week Highs On Friday
· Feb 21, 2020
-
Stocks That Hit 52-Week Highs On Thursday
· Feb 20, 2020
BABYF Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations collected by Financial Modeling Prep for BABYF.
Price Targets
Wall Street price target analysis for BABYF.
BABYF MoonshotScore
MoonshotScore is Stock Expert AI's proprietary 0-100 research rating, not a buy or sell recommendation. No MoonshotScore is published for BABYF; grades run from A+ (80-100) to F (below 30).
Leadership: Hamutal Yitzhak
CEO
Hamutal Yitzhak serves as the CEO of Else Nutrition Holdings Inc. Her background includes experience in the food and nutrition industry, with a focus on developing and marketing innovative products. She has a proven track record of leading teams and driving growth in competitive markets. Her expertise spans product development, marketing, and sales, with a strong emphasis on consumer-centric strategies. She is responsible for overseeing the company's overall strategy and operations.
Track Record: Under Hamutal Yitzhak's leadership, Else Nutrition has focused on expanding its product line and increasing its online sales presence. She has overseen the launch of new products and the development of strategic partnerships. Her focus on innovation and sustainability has helped Else Nutrition differentiate itself in the market. She manages 32 employees.
BABYF OTC Market Information
The OTC Other tier represents the lowest tier of the OTC market, indicating that Else Nutrition may not meet the minimum financial standards or reporting requirements of higher tiers like OTCQX or OTCQB. Companies in this tier may have limited financial disclosure, which increases investment risk. Unlike companies listed on major exchanges like the NYSE or NASDAQ, OTC Other companies often have less stringent listing requirements, leading to greater variability in company quality and transparency. Investors should exercise caution and conduct thorough due diligence before investing in OTC Other stocks.
- OTC Tier: OTC Other
- Limited financial disclosure.
- Low trading volume and liquidity.
- Potential for price volatility.
- Higher risk of fraud or manipulation.
- Less regulatory oversight compared to major exchanges.
- Verify the company's financial statements and SEC filings (if any).
- Research the company's management team and their track record.
- Assess the company's business model and competitive landscape.
- Evaluate the company's revenue and earnings growth potential.
- Check for any legal or regulatory issues.
- Monitor the stock's trading volume and price volatility.
- Consult with a financial advisor before investing.
- Company has a functional website and contact information.
- Products are available for sale online.
- Management team has relevant experience.
- Company has a clear business plan and strategy.
- Company is actively engaged in marketing and public relations.
Common Questions About BABYF (Consumer Defensive)
Is BABYF a good stock?
Stock Expert AI does not rate BABYF buy, sell or hold. Else Nutrition Holdings Inc. has no MoonshotScore yet; read the financial checkup, analyst consensus and risks directly. Whether it fits is your call: check what it sells, whether it earns, what the price assumes, and what would prove you wrong.
What does Else Nutrition Holdings Inc. do?
Else Nutrition Holdings Inc. develops, produces, and sells plant-based food and nutrition products for infants, toddlers, children, and adults. The company offers a range of products, including baby snacks, feeding accessories, plant-based baby formula, toddler nutrition, and complementary food products.
What are the key factors to evaluate for BABYF?
Evaluate BABYF on fundamentals, analyst consensus, and risk factors. Key value drivers include expanding its product line and increasing online sales. Not financial advice.
How frequently does BABYF data refresh on this page?
BABYF's price was last updated on Sep 11, 2026 and refreshes on page view during U.S. market hours; the quote is a provider snapshot, not an exchange feed. Fundamentals update after quarterly filings; the MoonshotScore recalculates nightly; news aggregates continuously.
What has driven BABYF's recent stock price performance?
Else Nutrition Holdings Inc. (BABYF) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Focus on plant-based nutrition. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider BABYF overvalued or undervalued right now?
Else Nutrition Holdings Inc. (BABYF) has no trailing P/E available here, so lean on price-to-sales and cash flow in the Financials tab. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
Can I buy fractional shares of BABYF?
Yes, most major brokerages offer fractional shares of Else Nutrition Holdings Inc. (BABYF) with no minimum purchase requirement. This means you can invest any dollar amount regardless of the share price. Check your brokerage platform for specific terms, fees, and fractional share availability.
How can I track BABYF's earnings and financial reports?
Else Nutrition Holdings Inc. (BABYF) reports quarterly earnings approximately 4-6 weeks after each fiscal quarter ends. You can track earnings dates, revenue and EPS estimates, and actual results on this page's Financials tab. Earnings surprises (beats or misses) often cause significant short-term price moves. Your brokerage can send alerts for BABYF earnings announcements.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Financial data is limited due to the company's OTC listing.